ArticleEuropean journal of human genetics : EJHG2025
"The ability to get ahead": Australian parent perspectives on genomics in newborn screening and considerations for potential models of care.
Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Healthcare professionals' views on expanding newborn screening with or without genomics in France: Results of the SeDeN-p2 study.European journal of human genetics : EJHG · 2026Article
- Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.The Medical journal of Australia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implementation of genomics in newborn screening is rapidly becoming a reality through accelerated clinical research and investment in genomic sequencing programs. The perspectives of parents who have experienced genetic screening and technologies can inform effective clinical translation and co-design of a model of care for future programs. Semi-structured interviews were undertaken with 23 parents of children diagnosed with genetic conditions. Data were evaluated using inductive content analysis methods. Parents valued expeditious, contemporary and accurate information from specialists to manage uncertainties and aid decision-making upon receiving a genomic diagnosis, alongside coordination and collaboration with local services to provide child and family centred care. Integration of psychosocial support into genomic NBS programs was highlighted as an important strategy to mitigate potential psychological risks of receiving a newborn genomic screening result. Integrating genomic NBS in current health ecosystems requires a model that provides care and support across the healthcare journey for the child and family. Information provision and consent at screening facilitates familial understanding of the implications of genomic screening. Equitable access to post screening care and expertise is essential to optimise health and psychosocial outcomes for the child and family and maintain parental acceptability.
Identifiers
41366567What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.